Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Clinical trial NCT07430956 · RECRUITING
Trial details
- NCT number
- NCT07430956
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-03
- Primary completion
- 2029-03-28
- Enrollment
- 2628
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.